Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

86
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
86
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

162
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
162
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

440
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
440
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

118
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
118
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

353
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
353
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.

The Lancet. Haematology·2026
Same author

[Sustainable healthcare transition: A guide for deprescribing unnecessary biological tests].

La Revue de medecine interne·2026
Same author

French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Gene Panel Analysis Through Genotyping or Sequencing in Pharmacogenetics.

Fundamental & clinical pharmacology·2026
Same author

The lipidome of the kidney tubules of ob/ob mice is affected at the infralesional level.

Cell death discovery·2025
Same author

Time course profiling of the kynurenine pathway activity in a pig model of crescentic glomerulonephritis.

BMC nephrology·2025
Same author

Interferon gamma induced-ACSL5 shapes the lipidome of kidney tubular cells.

iScience·2025

Related Experiment Video

Updated: Jun 25, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K

Long-term complications in acute porphyria.

Elena Pischik1, Mattias Lissing2,3, Nicolas Pallet4,5

  • 1Department of Neurology, Consultative and Diagnostic Centre with Polyclinics, St. Petersburg, Russia.

Liver International : Official Journal of the International Association for the Study of the Liver
|May 31, 2024
PubMed
Summary

Patients with acute porphyria (AP) now have normal life expectancy but face long-term risks like chronic pain and kidney disease. Preventing attacks is key to managing these chronic complications.

More Related Videos

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
12:27

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

16.5K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.4K

Related Experiment Videos

Last Updated: Jun 25, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
12:27

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

16.5K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.4K

Area of Science:

  • Medicine
  • Genetics
  • Neurology

Background:

  • Acute porphyria (AP) patients now have a life expectancy comparable to the general population due to improved treatments and reduced mortality.
  • This shift necessitates awareness of long-term health complications associated with AP.

Purpose of the Study:

  • To highlight the long-term complications of acute porphyria (AP).
  • To guide clinicians in managing chronic symptoms and comorbidities in AP patients.
  • To emphasize the importance of preventing recurrent attacks for better patient outcomes.

Main Methods:

  • Review of current clinical knowledge and treatment outcomes for acute porphyria.
  • Analysis of long-term complications including neuropathy, encephalopathy, hypertension, and kidney disease.
  • Discussion of diagnostic differentiation between acute and chronic symptoms and sequelae.

Main Results:

  • Long-term complications include chronic neuropathy, encephalopathy, hypertension, and kidney disease.
  • Patients have an increased risk of primary liver cancer (PLC), but not other cancers.
  • Chronic pain, fatigue, and nausea significantly impact quality of life, even in sporadic cases.
  • Distinguishing acute sequelae from chronic neuropathy is crucial for appropriate management.

Conclusions:

  • Preventing recurrent AP attacks is the most effective strategy for managing chronic comorbidities.
  • Personalized monitoring of blood pressure, renal function, and cardiovascular risk factors is essential.
  • Bi-annual surveillance for primary liver cancer is recommended for patients over 50, especially those with acute intermittent porphyria.